World Journal of Gastrointestinal Pharmacology and Therapeutics

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2089)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1087

Figures (1-5)

186

Tables (1-3)

226

Sum=1591

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

328

Sum=410

Mar 14, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Chen JF, Wu ZQ, Liu HS, Yan S, Wang YX, Xing M, Song XQ, Ding SY. Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China. World J Gastroenterol 2024; 30(10): 1346-1357 [PMID: 38596503 DOI: 10.3748/wjg.v30.i10.1346]
URL:	https://www.wjgnet.com/2150-5349/full/v30/i10/1346.htm

Number	Citing Articles
1	Tsvetelina Velikova, Milena Gulinac. Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure. World Journal of Gastroenterology 2024; 30(27): 3273-3277 doi: 10.3748/wjg.v30.i27.3273 Abstract(189) \| Core Tip(206) \| Full Article(HTML)(898) \| Full Article with Cover (PDF)-1171K(35) \| Audio-318K(4) \| Peer-Review Report-174K(18) \| Answering Reviewers-72K(16) \| Full Article (PDF)-367K(74) \| Full Article (XML)-61K(19) \| Times Cited (0) \| Total Visits (1705) \| Open
2	Wen-Xiu Liu, Lei Liu. Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction. World Journal of Hepatology 2024; 16(7): 990-994 doi: 10.4254/wjh.v16.i7.990 Abstract(164) \| Core Tip(137) \| Full Article(HTML)(662) \| Full Article with Cover (PDF)-9602K(30) \| Audio-377K(4) \| Peer-Review Report-181K(16) \| Answering Reviewers-331K(16) \| Full Article (PDF)-363K(61) \| Full Article (XML)-66K(18) \| Times Cited (0) \| Total Visits (1654) \| Open
3	Yanyan Xuan, Dingting Wu, Qin Zhang, Zhiqiang Yu, Jingbo Yu, Dongdong Zhou. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1457598
4	Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132 Abstract(186) \| Core Tip(188) \| Full Article(HTML)(921) \| Full Article with Cover (PDF)-880K(32) \| Audio-397K(4) \| Peer-Review Report-199K(18) \| Answering Reviewers-110K(23) \| Full Article (PDF)-408K(84) \| Full Article (XML)-131K(23) \| Times Cited (0) \| Total Visits (1982) \| Open
5	Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576 Abstract(22) \| Core Tip(17) \| Full Article(HTML)(68) \| Full Article with Cover (PDF)-644K(7) \| Audio-887K(0) \| Peer-Review Report-177K(6) \| Answering Reviewers-110K(6) \| Full Article (PDF)-421K(6) \| Full Article (XML)-115K(5) \| Times Cited (0) \| Total Visits (188) \| Open
6	Amedeo Lonardo. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024; 30(24): 3016-3021 doi: 10.3748/wjg.v30.i24.3016 Abstract(166) \| Core Tip(158) \| Full Article(HTML)(784) \| Full Article with Cover (PDF)-629K(40) \| Audio-810K(8) \| Peer-Review Report-260K(25) \| Answering Reviewers-141K(19) \| Full Article (PDF)-401K(70) \| Full Article (XML)-71K(26) \| Times Cited (1) \| Total Visits (1713) \| Open
7	Chen-Xiao Huang, Xiao-Dong Zhou, Calvin Q Pan, Ming-Hua Zheng. Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor’s clothes of normal liver enzymes?. World Journal of Gastroenterology 2024; 30(22): 2839-2842 doi: 10.3748/wjg.v30.i22.2839 Abstract(182) \| Core Tip(179) \| Full Article(HTML)(753) \| Full Article with Cover (PDF)-599K(129) \| Audio-841K(4) \| Peer-Review Report-169K(27) \| Answering Reviewers-75K(26) \| Full Article (PDF)-345K(94) \| Full Article (XML)-41K(21) \| Times Cited (0) \| Total Visits (2059) \| Open
8	Giovanna McGinty, Robert Przemioslo. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World Journal of Gastroenterology 2024; 30(27): 3264-3267 doi: 10.3748/wjg.v30.i27.3264 Abstract(204) \| Core Tip(165) \| Full Article(HTML)(1030) \| Full Article with Cover (PDF)-1163K(41) \| Audio-772K(4) \| Peer-Review Report-171K(18) \| Answering Reviewers-104K(31) \| Full Article (PDF)-359K(90) \| Full Article (XML)-59K(27) \| Times Cited (1) \| Total Visits (1904) \| Open

Number	Citing Articles
1	Tsvetelina Velikova, Milena Gulinac. Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure. World Journal of Gastroenterology 2024; 30(27): 3273-3277 doi: 10.3748/wjg.v30.i27.3273 Abstract(189) \| Core Tip(206) \| Full Article(HTML)(898) \| Full Article with Cover (PDF)-1171K(35) \| Audio-318K(4) \| Peer-Review Report-174K(18) \| Answering Reviewers-72K(16) \| Full Article (PDF)-367K(74) \| Full Article (XML)-61K(19) \| Times Cited (0) \| Total Visits (1705) \| Open
2	Wen-Xiu Liu, Lei Liu. Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction. World Journal of Hepatology 2024; 16(7): 990-994 doi: 10.4254/wjh.v16.i7.990 Abstract(164) \| Core Tip(137) \| Full Article(HTML)(662) \| Full Article with Cover (PDF)-9602K(30) \| Audio-377K(4) \| Peer-Review Report-181K(16) \| Answering Reviewers-331K(16) \| Full Article (PDF)-363K(61) \| Full Article (XML)-66K(18) \| Times Cited (0) \| Total Visits (1654) \| Open
3	Yanyan Xuan, Dingting Wu, Qin Zhang, Zhiqiang Yu, Jingbo Yu, Dongdong Zhou. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1457598
4	Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132 Abstract(186) \| Core Tip(188) \| Full Article(HTML)(921) \| Full Article with Cover (PDF)-880K(32) \| Audio-397K(4) \| Peer-Review Report-199K(18) \| Answering Reviewers-110K(23) \| Full Article (PDF)-408K(84) \| Full Article (XML)-131K(23) \| Times Cited (0) \| Total Visits (1982) \| Open
5	Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576 Abstract(22) \| Core Tip(17) \| Full Article(HTML)(68) \| Full Article with Cover (PDF)-644K(7) \| Audio-887K(0) \| Peer-Review Report-177K(6) \| Answering Reviewers-110K(6) \| Full Article (PDF)-421K(6) \| Full Article (XML)-115K(5) \| Times Cited (0) \| Total Visits (188) \| Open
6	Amedeo Lonardo. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024; 30(24): 3016-3021 doi: 10.3748/wjg.v30.i24.3016 Abstract(166) \| Core Tip(158) \| Full Article(HTML)(784) \| Full Article with Cover (PDF)-629K(40) \| Audio-810K(8) \| Peer-Review Report-260K(25) \| Answering Reviewers-141K(19) \| Full Article (PDF)-401K(70) \| Full Article (XML)-71K(26) \| Times Cited (1) \| Total Visits (1713) \| Open
7	Chen-Xiao Huang, Xiao-Dong Zhou, Calvin Q Pan, Ming-Hua Zheng. Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor’s clothes of normal liver enzymes?. World Journal of Gastroenterology 2024; 30(22): 2839-2842 doi: 10.3748/wjg.v30.i22.2839 Abstract(182) \| Core Tip(179) \| Full Article(HTML)(753) \| Full Article with Cover (PDF)-599K(129) \| Audio-841K(4) \| Peer-Review Report-169K(27) \| Answering Reviewers-75K(26) \| Full Article (PDF)-345K(94) \| Full Article (XML)-41K(21) \| Times Cited (0) \| Total Visits (2059) \| Open
8	Giovanna McGinty, Robert Przemioslo. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World Journal of Gastroenterology 2024; 30(27): 3264-3267 doi: 10.3748/wjg.v30.i27.3264 Abstract(204) \| Core Tip(165) \| Full Article(HTML)(1030) \| Full Article with Cover (PDF)-1163K(41) \| Audio-772K(4) \| Peer-Review Report-171K(18) \| Answering Reviewers-104K(31) \| Full Article (PDF)-359K(90) \| Full Article (XML)-59K(27) \| Times Cited (1) \| Total Visits (1904) \| Open